CdGAP Antibodies

Santa Cruz Biotechnology delivers a wide array of CdGAP Antibodies for advanced research in cellular signaling and cytoskeletal dynamics. CdGAP Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CdGAP, or Cdc42 GTPase-activating protein, plays a crucial role in regulating the activity of the Cdc42 protein, which is involved in cell morphology, migration, and proliferation. By modulating Cdc42 signaling pathways, CdGAP influences various cellular processes, making it an important target for understanding cancer progression and other diseases. The study of CdGAP is essential for elucidating the mechanisms of cell behavior and developing potential therapeutic strategies. CdGAP research has revealed significant insights into cellular regulation and disease development. Understanding CdGAP function continues to advance knowledge in cell biology and pathology. Santa Cruz Biotechnology monoclonal antibodies for CdGAP support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.